Johns Hopkins Bloomberg School of Public Health: The INFO Project

Your knowledge-sharing resource on family planning and reproductive health

Shopping Basket

What are the benefits of registering?

Main Navigation:

Products &
Services -

Publications -

Databases -

eLearning -

Networks &
Communities -

Knowledge
Management -

Browse
Topics -

Search One Source -

Dr. Jim Shelton's Pearls

What are "Pearls?" – Pearl of the Week – Archive – Español – Français – Ask a Question

"Pearl" for the week of April 4, 2006
Transition from Norplant to Jadelle

Since Norplant is being phased out, is there any developing country experience in the transition to either Jadelle or Implanon?

Yes. The transition at the Profamilia clinic in the Dominican Republic has been recently described and (at least in the context of this high quality, high volume clinic) the transition from Norplant to Jadelle went smoothly. The very experienced staff needed little training.

In a study of 249 women, 53% preferred Jadelle, primarily because of: the reduced number of implants; easier insertion and removal; and less visibility in the arm. Those who preferred Norplant did so mainly because of greater familiarity with it, but a few also because of the potential for longer use.

Reference: Brache V et al. Transition from Norplant to Jadelle in a clinic with extensive experience providing contraceptive implants. Contraception 2006; 73:364-7.

The "Pearls" offer answers to commonly asked questions about family planning. These "Pearls" are prepared by Dr. James D. Shelton, Senior Medical Scientist, Office of Population, United States Agency for International Development (USAID)

Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.